Abstract:Background: Studies have shown that the natural products of Astragalus membranaceus (AM) can effectively interfere with a variety of cancers, but their mechanism of action on breast cancer remains unclear. Triple-negative breast cancer (TNBC) is associated with a severely poor prognosis due to its invasive phenotype and lack of biomarker-driven-targeted therapies. In this study, the potential mechanism of the target composition acting on TNBC was explored by integrated pharmacological models and in vitro experiments.Materials and Methods: Based on the Gene Expression Omnibus (GEO) database and the relational database of Traditional Chinese Medicines (TCMs), the drug and target components were initially screened to construct a common network module, and multiattribute analysis was then used to characterize the network and obtain key drug-target information. Furthermore, network topology analysis was used to characterize the betweenness and closeness of key hubs in the network. Molecular docking was used to evaluate the affinity between compounds and targets and obtain accurate combination models. Finally, in vitro experiments verified the key component targets. The cell counting kit-8 (CCK-8) assay, invasion assay, and flow cytometric analysis were used to assess cell viability, invasiveness, and apoptosis, respectively, after Astragalus polysaccharides (APS) intervention. We also performed western blot analysis of key proteins to probe the mechanisms of correlated signaling pathways.Results: We constructed "compound-target" (339 nodes and 695 edges) and "compound-disease" (414 nodes and 6458 edges) networks using interaction data. Topology analysis and molecular docking were used as secondary screens to identify key hubs of the network. Finally, the key component APS and biomarkers PIK3CG, AKT, and BCL2 were identified. The in vitro experimental results confirmed that APS can effectively inhibit TNBC cell activity, reduce invasion, promote apoptosis, and then counteract TNBC symptoms in a dose-dependent manner, most likely by inhibiting the PIK3CG/AKT/BCL2 pathway.Conclusion: This study provides a rational approach to discovering compounds with a polypharmacology-based therapeutic value. Our data established that APS intervenes with TNBC cell invasion, proliferation, and apoptosis via the PIK3CG/AKT/BCL2 pathway and could thus offer a promising therapeutic strategy for TNBC.

Inhibition of growth and metastasis of triple-negative breast cancer targeted by Traditional Chinese Medicine Tubeimu in orthotopic mice models

The Potential Role of Tubeimosides in Cancer Prevention and Treatment

Real-time Imaging of Apoptosis Induction of Human Breast Cancer Cells by the Traditional Chinese Medicinal Herb Tubeimu.

The signaling pathways and targets of traditional Chinese medicine and natural medicine in triple-negative breast cancer

Exploring the Potential Use of Chinese Herbs in Regulating the Inflammatory Microenvironment of Tumours Based on the Concept of ‘State-Target Identification and Treatment’: a Scooping Review

High-Throughput In Vitro Gene Expression Profile to Screen of Natural Herbals for Breast Cancer Treatment

Discovery of a Natural Small-Molecule Compound That Suppresses Tumor EMT, Stemness and Metastasis by Inhibiting TGFβ/BMP Signaling in Triple-Negative Breast Cancer

Imageable Orthothopic Metastatic Mouse Models for the Identification of the Antitumor and Antimetastatic Efficacy of Traditional Chinese Medicine (Tcm)

The Modulatory Properties of Astragalus membranaceus Treatment on Triple-Negative Breast Cancer: An Integrated Pharmacological Method

Growth Inhibitory Efficacy of Chinese Herbs in a Cellular Model for Triple-Negative Breast Cancer

A modified natural small molecule inhibits triple-negative breast cancer growth by interacting with Tubb3

Tiamulin inhibits breast cancer growth and pulmonary metastasis by decreasing the activity of CD73

Unraveling the Action Mechanism of Tubeimoside-1 against Tumor Microvessels via Network Pharmacology and Experimental Validation

Jianpi‐Tiaoqi decoction inhibits tumour proliferation and lung metastasis in tumour‐bearing mice with triple‐negative breast cancer

The therapeutic effect of traditional Chinese medicine on breast cancer through modulation of the Wnt/β-catenin signaling pathway

Tubeimoside-1: A review of its antitumor effects, pharmacokinetics, toxicity, and targeting preparations

AI-based Virtual Screening of Traditional Chinese Medicine and the Discovery of Novel Inhibitors of TCTP

Unveiling the therapeutic potential: KBU2046 halts triple-negative breast cancer cell migration by constricting TGF-β1 activation in vitro

Traditional Chinese Medicine (Tcm) Enhances Efficacy And Reduces Toxicity Of Tumor-Targeting S. Typhimurium A1-R In A Syngeneic Breast Cancer Metastatic Mouse Model

Anti-cancer Activity of Centipeda minima Extract in Triple Negative Breast Cancer via Inhibition of AKT, NF-κB, and STAT3 Signaling Pathways

Abstract 579: Chinese Herbal Mixture LQ Inhibits Tumor Growth and Metastasis and Increases Survival in Orthotopic and Other Mouse Models of Human and Mouse Cancer